LACIE SANDERSON: Open Payments
NPI 1578900890 · NEWPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 36 payments from 15 companies in 2025. Trend: 2023 $521 · 2024 $630 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $206 |
| Novo Nordisk Inc | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| CeQur Corporation | 1 | $48 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Sonex Health, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: VRAYLAR, UBRELVY, AIRSUPRA, Wegovy, JARDIANCE, CeQur Simplicity, ROTATEQ, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
